Andrew James Norstrud - 21 Jul 2021 Form 4 Insider Report for GROVE, INC. (UPXI)

Reporting relationship: CFO
Issuer ticker: UPXI
Reported as of: 21 Jul 2021
Net transaction value: $0
SEC form: 4
Accepted by SEC: 30 Aug 2021, 19:11:17 UTC
Prior SEC filing: 24 Jun 2021
Next SEC filing: 28 Dec 2021
Source filing: View source filing
Reporting owner signature: /s/ Andrew Norstrud

Key filing fact

Andrew James Norstrud filed Form 4 for GROVE, INC. (UPXI) on 30 Aug 2021.

Key facts

This page summarizes Andrew James Norstrud's Form 4 filing for GROVE, INC. (UPXI).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 30 Aug 2021, 19:11.

Change

Previous filing in this sequence was filed on 24 Jun 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001311402 Primary reporting owner

Norstrud Andrew James

Relationship: CFO
Address: 1710 WHITNEY MESA DRIVE, C/O GROVE INC., HENDERSON
Signature: /s/ Andrew Norstrud
Signature date: 30 Aug 2021

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

UPXI transaction Derivative

Option Grant

Award

Transaction value
Shares: +200,000
Change %
Price
Shares after: 200,000
Date: 21 Jul 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 200,000
Exercise price
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

200,000 options are vested and shall be exercisable for a price of $4.18 per option share for 2 years from July 21, 2021 (the "Grant Date"); such options shall vest on a monthly basis over a one year period and be exercisable for a price of $4.18 per option share for two years from the Grant Date.